Recombinant HBV surface antigen subunit vaccine (Center for Genetic Engineering and Biotechnology)

N/A

Report date: 2024/12/11 10:05:02

Base Information

Drug NameRecombinant HBV surface antigen subunit vaccine (Center for Genetic Engineering and Biotechnology)
Drug Alias NameHeberbiovac HB
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis DHepatitis B
Global Approved IndicationsHepatitis DHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2000/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesCenter For Genetic Engineering And Biotechnology
Inactive CompaniesN/A
Active IndicationsHepatitis DHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01
Related LinksN/A